MORGAN STANLEY

Position in ALMS — Alumis Inc.

CIK 895421 NEW YORK, NY

Position in ALMS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,958,334

+$14,615 QoQ

Shares Held

225,072

-55.6% QoQ

Ownership

0.177%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 89.71795692045212.ToString("F0")% Shared 0.ToString("F0")% None 10.28204307954788.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. ALMS ranks #174 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,958,334	225,072	-55.6%	Shares	Defined	2026-05-15
2025-12-31	$4,943,719	506,529	+52.4%	Shares	Defined	2026-05-27
2025-09-30	$1,326,297	332,406	-2.0%	Shares	Defined	2026-05-27
2025-06-30	$1,017,297	339,099	+48.1%	Shares	Defined	2025-08-15
2025-03-31	$1,406,045	228,998	+383.9%	Shares	Defined	2025-05-15
2024-12-31	$371,941	47,321	+24.1%	Shares	Defined	2025-05-15
2024-09-30	$407,087	38,117	-89.8%	Shares	Defined	2025-05-14
2024-06-30	$4,987,500	375,000	—	Shares	Defined	2025-05-14
No filing history on record for this holder in this stock.